DMG Group »

Kymera Therapeutics shares owned by DMG Group

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by DMG Group from 13F filings

Historical chart of DMG Group investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by DMG Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by DMG Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $229k 2.0k 114.67

More positions owned by DMG Group

Apple Stock (AAPL)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
State Street Spdr Bloomberg St Intl Tsy Bd Etf Etf (BWZ)
Advanced Micro Devices Stock (AMD)
Ishares 1-5yr Corporate Bond Etf Etf (IGSB)
Ishares International Treasury Bond Etf Etf (IGOV)
Intel Corp Stock (INTC)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Ishares 5-10yr Corporate Bond Etf Etf (IGIB)
Microsoft Corp Stock (MSFT)
Ishares 0-5 Year Tips Bond Etf Etf (STIP)
Kla Corp Stock (KLAC)
Amazon Stock (AMZN)
Ishares U.s. Treasury Bond Etf Etf (GOVT)
Cisco Sys Stock (CSCO)

View all positions for DMG Group

Top funds holding Kymera Therapeutics

FMR
Baker Bros. Advisors
venBio Select Advisor
T. Rowe Price Associates
BlackRock
BVF
Wellington Management Company
Vanguard Portfolio Management
Siren
Vanguard Capital Management
Atlas Venture Life Science Advisors
State Street Corporation
Geode Capital Management
Capital Research Global Investors
Goldman Sachs Group

View all funds holding Kymera Therapeutics